More fake Xeplion withdrawn in Denmark

By Gareth Macdonald

A fourth batch of Janssen-Cilag’s schizophrenia drug Xeplion has been withdrawn in Denmark after the identification of counterfeit packs.

Merck joins in generics M&A

Merck joins in generics M&A

Faced with a raft of consolidation in the market for generic
pharmaceuticals, Germany's Merck KGaA has entered the fray with an
agreement to acquire most of NM Pharma, the Scandinavian generics
business of top drugmaker Pfizer.

HQ for Euro biotech

HQ for Euro biotech

The European Federation of Biotechnology (EFB) is setting up a
trade office in Aarhus, Denmark for its activities in innovation
and functional genomics, reports Biotech Denmark on its website.


Follow us


View more


Featured Suppliers